Jerusalem, 26 November, 2025 (TPS-IL) — NanoPass Technologies, an Israeli medical-tech company based in Nes Ziona, expanded its global footprint with new distribution agreements in Singapore, Mexico, Colombia and Australia. The deals bring NanoPass’s reach to more than 30 countries as it pushes to make its MicronJet device the global standard for intradermal drug and aesthetic delivery.
The company, which develops MEMS-based silicon micro-needles, has gained approvals from regulators including the U.S. FDA and the EU CE.